老虎證券

BUZZ-PTC Therapeutics falls after withdrawing muscle disorder drug marketing application

Reuters
02/13
BUZZ-PTC <a href="https://laohu8.com/S/LENZ">Therapeutics</a> falls after withdrawing muscle disorder drug marketing application

** Shares of PTC Therapeutics PTCT.O fall 5.2% to $67.05 after markets

** Co says it has withdrawn its marketing application resubmission for its muscle disorder drug Translarna

** "FDA shared that based on its review to date, the data in the NDA submission are unlikely to meet the agency's threshold of substantial evidence of effectiveness to support approval of Translarna", says PTCT

** Last year co said the drug will no longer be available for sale in the EU as the European Commission has decided not to renew its marketing authorization

** The drug is designed to boost production of a protein called dystrophin, the absence of which causes muscle weakening in patients with Duchenne muscular dystrophy

** PTCT was up 68.3% in 2025

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))

應版權方要求，你需要登入查看該內容

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10